Andre Rodrigues Duraes, Mansueto Gomes-Neto, Edimar Alcides Bocchi
{"title":"社论:机器学习和人工智能在心力衰竭管理中的当代应用。","authors":"Andre Rodrigues Duraes, Mansueto Gomes-Neto, Edimar Alcides Bocchi","doi":"10.3389/fcvm.2025.1611859","DOIUrl":null,"url":null,"abstract":"<p><p>Heart failure (HF) is a complex syndrome with substantial clinical and economic impact. This editorial highlights four original articles published in <i>Frontiers in Cardiovascular Medicine</i> that showcase contemporary applications of machine learning and artificial intelligence (AI) in HF management. These studies address early diagnosis through novel biomarkers, disease stratification based on transcriptomics, mechanistic insight into apoptotic pathways, and predictive telemonitoring using real-time AI models. Collectively, these contributions exemplify the transformative potential of data-driven technologies in personalizing care and preventing decompensation in HF. We discuss both the promise and challenges of integrating these tools into routine.</p>","PeriodicalId":12414,"journal":{"name":"Frontiers in Cardiovascular Medicine","volume":"12 ","pages":"1611859"},"PeriodicalIF":2.8000,"publicationDate":"2025-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12170515/pdf/","citationCount":"0","resultStr":"{\"title\":\"Editorial: Contemporary applications of machine learning and artificial intelligence for the management of heart failure.\",\"authors\":\"Andre Rodrigues Duraes, Mansueto Gomes-Neto, Edimar Alcides Bocchi\",\"doi\":\"10.3389/fcvm.2025.1611859\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Heart failure (HF) is a complex syndrome with substantial clinical and economic impact. This editorial highlights four original articles published in <i>Frontiers in Cardiovascular Medicine</i> that showcase contemporary applications of machine learning and artificial intelligence (AI) in HF management. These studies address early diagnosis through novel biomarkers, disease stratification based on transcriptomics, mechanistic insight into apoptotic pathways, and predictive telemonitoring using real-time AI models. Collectively, these contributions exemplify the transformative potential of data-driven technologies in personalizing care and preventing decompensation in HF. We discuss both the promise and challenges of integrating these tools into routine.</p>\",\"PeriodicalId\":12414,\"journal\":{\"name\":\"Frontiers in Cardiovascular Medicine\",\"volume\":\"12 \",\"pages\":\"1611859\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-06-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12170515/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Cardiovascular Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fcvm.2025.1611859\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Cardiovascular Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fcvm.2025.1611859","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Editorial: Contemporary applications of machine learning and artificial intelligence for the management of heart failure.
Heart failure (HF) is a complex syndrome with substantial clinical and economic impact. This editorial highlights four original articles published in Frontiers in Cardiovascular Medicine that showcase contemporary applications of machine learning and artificial intelligence (AI) in HF management. These studies address early diagnosis through novel biomarkers, disease stratification based on transcriptomics, mechanistic insight into apoptotic pathways, and predictive telemonitoring using real-time AI models. Collectively, these contributions exemplify the transformative potential of data-driven technologies in personalizing care and preventing decompensation in HF. We discuss both the promise and challenges of integrating these tools into routine.
期刊介绍:
Frontiers? Which frontiers? Where exactly are the frontiers of cardiovascular medicine? And who should be defining these frontiers?
At Frontiers in Cardiovascular Medicine we believe it is worth being curious to foresee and explore beyond the current frontiers. In other words, we would like, through the articles published by our community journal Frontiers in Cardiovascular Medicine, to anticipate the future of cardiovascular medicine, and thus better prevent cardiovascular disorders and improve therapeutic options and outcomes of our patients.